Price T Rowe Associates Inc Zai Lab LTD Transaction History

Price T Rowe Associates Inc

$867 Billion
Q4 2024

A detailed history of Price T Rowe Associates Inc transactions in Zai Lab LTD stock. As of the latest transaction made, Price T Rowe Associates Inc holds 2,354,025 shares of ZLAB stock, worth $79.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,354,025

Previous 1,805,647 30.37%

Holding current value

$79.5 Million

Previous $43.6 Million 41.44%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$24.61 - $33.18 $13.5 Million - $18.2 Million	548,378 Added 30.37%	2,354,025 $61.7 Million
Q3 2024 Nov 14, 2024	BUY	$16.25 - $24.14 $2.4 Million - $3.57 Million	147,732 Added 8.91%	1,805,647 $43.6 Million
Q2 2024 Aug 14, 2024	BUY	$13.72 - $21.55 $97,796 - $153,608	7,128 Added 0.43%	1,657,915 $28.7 Million
Q1 2024 May 15, 2024	SELL	$15.95 - $26.8 $16.8 Million - $28.2 Million	-1,053,668 Reduced 38.96%	1,650,787 $26.4 Million
Q4 2023 Feb 14, 2024	SELL	$22.97 - $30.58 $278,832 - $371,210	-12,139 Reduced 0.45%	2,704,455 $73.9 Million
Q3 2023 Nov 14, 2023	BUY	$22.72 - $31.49 $2.08 Million - $2.88 Million	91,479 Added 3.48%	2,716,594 $66 Million
Q2 2023 Aug 14, 2023	BUY	$25.3 - $39.67 $5.46 Million - $8.56 Million	215,742 Added 8.95%	2,625,115 $72.8 Million
Q1 2023 May 15, 2023	BUY	$30.21 - $48.1 $27.9 Million - $44.4 Million	923,108 Added 62.11%	2,409,373 $80.1 Million
Q4 2022 Feb 14, 2023	SELL	$22.28 - $38.71 $2.71 Million - $4.7 Million	-121,416 Reduced 7.55%	1,486,265 $45.6 Million
Q3 2022 Nov 14, 2022	BUY	$34.2 - $51.69 $4.83 Million - $7.3 Million	141,271 Added 9.63%	1,607,681 $55 Million
Q2 2022 Aug 15, 2022	SELL	$23.14 - $49.68 $1.24 Million - $2.66 Million	-53,607 Reduced 3.53%	1,466,410 $50.9 Million
Q1 2022 May 16, 2022	BUY	$27.77 - $64.4 $4.03 Million - $9.34 Million	145,053 Added 10.55%	1,520,017 $66.9 Million
Q4 2021 Feb 14, 2022	BUY	$54.9 - $105.21 $450,015 - $862,406	8,197 Added 0.6%	1,374,964 $86.4 Million
Q3 2021 Nov 15, 2021	BUY	$105.0 - $178.37 $27.6 Million - $46.9 Million	262,800 Added 23.81%	1,366,767 $144 Million
Q2 2021 Aug 16, 2021	BUY	$125.11 - $180.0 $5.29 Million - $7.62 Million	42,319 Added 3.99%	1,103,967 $195 Million
Q1 2021 May 17, 2021	BUY	$126.27 - $191.71 $19.3 Million - $29.3 Million	152,819 Added 16.81%	1,061,648 $142 Million
Q4 2020 Feb 16, 2021	BUY	$81.94 - $135.34 $74.5 Million - $123 Million	908,829 New	908,829 $123 Million

Others Institutions Holding ZLAB

# of Institutions

146

Shares Held

53M

Call Options Held

103K

Put Options Held

439K

View Full List

About Zai Lab Ltd

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $3.31B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

More about ZLAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Zai Lab LTD Transaction History